Paper Details

  1. Home
  2. Paper Details

Effects of on-demand beta2-agonist inhalation in moderate-to-severe asthma. A randomized controlled trial.

Author: BenderR, BergerM, RichterB

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

On-demand inhalation of short-acting beta2-agonists in moderate-to-severe asthma is safe and possible, with improved asthma control.
Paper Details　
Original Abstract of the Article :
BACKGROUND: The appropriate use of short-acting beta2-agonist inhalation in asthma has been the subject of controversy in recent years. Limited information is available for the group of moderate to severe asthmatics with high intake of bronchodilator inhalants and continuous anti-inflammatory protec...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1046/j.1365-2796.2000.00677.x

データ提供：米国国立医学図書館（NLM）

On-Demand Beta2-Agonist Inhalation: A Breath of Fresh Air in the Desert of Asthma

The desert of asthma can be a challenging place, marked by shortness of breath and unpredictable symptoms. This study investigates the effectiveness of reducing beta2-agonist inhalation in patients with moderate-to-severe asthma, exploring a potential shift from regular to on-demand use of this commonly prescribed medication.

On-Demand Beta2-Agonist Inhalation: A Promising Approach

The researchers conducted a randomized controlled trial involving 80 adult patients with moderate-to-severe asthma. They found that over 80% of these patients could safely reduce their beta2-agonist intake by at least 50%. Moreover, the study revealed that on-demand inhalation resulted in improved asthma control, demonstrating its potential to enhance patient well-being.

Navigating the Sands of Asthma Management

This study provides valuable insights into the management of asthma. It suggests that on-demand beta2-agonist inhalation can be an effective and safe approach for patients with moderate-to-severe asthma, offering a potential breath of fresh air in the desert of this chronic condition.

Dr.Camel's Conclusion

This study suggests that on-demand beta2-agonist inhalation can offer a breath of fresh air in the desert of asthma management. The findings provide valuable insights into the potential for reducing medication use while maintaining or improving asthma control, potentially making the journey through this condition a bit more manageable.

Date :
  1. Date Completed 2000-07-25
  2. Date Revised 2019-09-05
Further Info :

Pubmed ID

10886487

DOI: Digital Object Identifier

10.1046/j.1365-2796.2000.00677.x

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.